Litcius/Paper detail

Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?

Cecilia T. Costiniuk, Mohammad-Ali Jenabian

2020Cytokine & Growth Factor Reviews50 citationsDOIOpen Access PDF

Topics & Concepts

CannabidiolPathogenesisInflammationMedicineImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyDiseasePathologyInfectious disease (medical specialty)CannabisPsychiatryCannabis and Cannabinoid Research
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment? | Litcius